Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

38.38
BATS BZX Real-Time Price
As of 2:11pm ET
 -0.04 / -0.10%
Today’s Change
36.00
Today|||52-Week Range
46.22
-14.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Operating ActivitiesNet Income / Starting Line767.0M316.0M615.0M-329.0M
 
 
 
 
 
Depreciation366.0M347.0M347.0M340.0M
 
 
 
 
 
Total Other Cash Flow22.0M629.0M62.0M1.0B
 
 
 
 
 
Funds From Operations1.2B1.3B1.0B1.0B
 
 
 
 
 
Extraordinary Items0.00-25.0M0.000.00
 
 
Funds From/For Other Operating Expenses327.0M1.4B115.0M-206.0M
 
 
 
 
 
Net Cash Flow - Operating Activities828.0M-93.0M909.0M1.2B
 
 
 
 
 
 
InvestingIncrease In Investments-2.3B-----182.0M
 
 
 
Decrease In Investments--446.0M-446.0M0.00
 
 
 
Capital Expenditures-248.0M-243.0M-247.0M-312.0M
 
 
 
 
 
Fixed Asset Disposal-2.3B25.0M0.000.00
 
 
 
Net Assets From Acquisitions 0.00-----66.0M
 
 
Other Investing - Uses0.00-2.0M2.0M0.00
 
 
 
Other Investing - Sources9.0M0.0028.0M6.0M
 
 
 
 
Net Cash Flow Investing1.6B226.0M-1.5B-554.0M
 
 
 
 
 
 
FinancingShort Term Borrowings738.0M-583.0M298.0M-397.0M
 
 
 
 
 
Long Term Borrowings0.000.00-132.0M-38.0M
 
 
 
Long Term Debt Reduction-21.0M-7.0M-3.0M-1.0M
 
 
 
 
 
Net Proceeds Stock Sale51.0M87.0M43.0M76.0M
 
 
 
 
 
Common Preferred Redeemed-888.0M-519.0M-1.0M-2.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-360.0M-385.0M-384.0M-384.0M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing17.0M25.0M0.000.00
 
 
 
Net Cash Flow - Financing-497.0M-1.4B-179.0M-746.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-28.0M-368.0M-16.0M5.0M
 
 
 
 
 
 
Net Change In Cash1.9B-1.3B-740.0M-83.0M